Does GEMCITABINE Cause Diffuse large b-cell lymphoma refractory? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Diffuse large b-cell lymphoma refractory have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.4% of all adverse event reports for GEMCITABINE.
124
Reports of Diffuse large b-cell lymphoma refractory with GEMCITABINE
0.4%
of all GEMCITABINE reports
22
Deaths
23
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From GEMCITABINE?
Of the 124 reports, 22 (17.7%) resulted in death, 23 (18.5%) required hospitalization, and 13 (10.5%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which GEMCITABINE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN